KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest Expense - DebtInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Knowles (KN) Research & Development (2016 - 2026)

Knowles has reported Research & Development over the past 14 years, most recently at $11.7 million for Q1 2026.

  • Quarterly Research & Development rose 20.62% to $11.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $42.2 million through Mar 2026, up 6.03% year-over-year, with the annual reading at $40.2 million for FY2025, 1.77% up from the prior year.
  • Research & Development was $11.7 million for Q1 2026 at Knowles, up from $10.5 million in the prior quarter.
  • Over five years, Research & Development peaked at $23.1 million in Q1 2022 and troughed at -$34.4 million in Q4 2022.
  • The 5-year median for Research & Development is $10.2 million (2024), against an average of $10.4 million.
  • Year-over-year, Research & Development plummeted 252.21% in 2022 and then soared 124.42% in 2023.
  • A 5-year view of Research & Development shows it stood at -$34.4 million in 2022, then soared by 124.42% to $8.4 million in 2023, then grew by 22.62% to $10.3 million in 2024, then rose by 1.94% to $10.5 million in 2025, then grew by 11.43% to $11.7 million in 2026.
  • Per Business Quant, the three most recent readings for KN's Research & Development are $11.7 million (Q1 2026), $10.5 million (Q4 2025), and $10.0 million (Q3 2025).